Ke ʻimi nei i ka hana ʻana o ka protein Recombinant me TECNIC'S Biotech Solutions
I loko o ke aupuni ikaika o nā meaʻenehana, hana ʻana i nā protein recombinant ua lilo i kekahi o nā ʻenehana nui e hana i nā huahana protein makemake nui ʻia no ka nui o nā noi ʻepekema ola, e like me ka noiʻi olakino a me nā lāʻau lapaʻau.
I ka wā ma mua, ʻo ke ala nui e loaʻa ai kahi protein kikoʻī ʻo ka hoʻokaʻawale ʻana iā ia mai kahi kumu kūlohelohe, ʻaʻole kūpono a me ka manawa-consumana. Eia nō naʻe, mahalo i nā holomua hou i ka genetic engineering a me ka recombinant mole biological techniques, ua hoʻololi ʻia ka ʻāina biotech, i hiki ai ke hōʻike i nā protein recombinant maʻamau i loko o nā ʻōnaehana hōʻike i hoʻolaʻa ʻia, e like me ka bacteria, yeast, cell cell, algal system and mammalian cell.
keia mea hou biotechnological ʻAʻole i lilo wale i kumu no ka biomedicine a me nā bioprocesses lāʻau lapaʻau, akā i nā noi biotech ʻē aʻe, e hāʻawi ana i nā hopena hou i nā pilikia honua. Ke hoʻomau nei kēia ʻenehana i ka ulu ʻana, hiki i kāna mau ʻōlelo hoʻohiki e hoʻololi hou i kā mākou ala i nā ʻano ʻepekema ola.
At Tecnic ʻike mākou i ke kuleana koʻikoʻi a nā protein recombinant e pāʻani ai i ka biotechnology, a no ia kumu, hōʻoia mākou e hoʻolālā ʻia kā mākou mea hana hou e hoʻokiʻekiʻe a hoʻonui i kāna hana me ka hoʻokōʻana, pololei a ka palekana. Hāʻawi kā mākou ʻano bioreactors i nā mea noiʻi a me nā mea hana ʻoihana e hoʻokō hoʻonui i ka hua, a ʻae kā mākou ʻōnaehana TFF easy and automatic purification o ka huahana i makemakeia.
Explore the infinite possibilities with Tecnic and choose us to work with a partner committed to catalyze breakthroughs in production efficiency through our innovation solutions.
He aha nā protein recombinant?
Inā ʻo ka protein ka mea hana i nā ʻōnaehana olaola, e hoʻokele i ka hapa nui o nā bioprocesses cell, nā pūmua hou ʻo ia kēlā mau hōʻike ʻia mai kahi gene DNA recombinant, ka mea i hala hana ʻenehana e hoʻopaʻa ʻia i loko o kahi hōʻike vector. Ke hoʻokomo ʻia i loko o ka mea hoʻokipa, kākoʻo ka vector i ka hōʻike protein recombinant ma o ka unuhi ʻana a me ka unuhi RNA ma hope mai i loko o nā keena hoʻokipa i makemake ʻia.
ka mea hoʻokipa (no ka laʻana E. coli), i kēia manawa genetically modified, essentially became a specialized factory for the ka hana ʻana o ka protein recombinant. He waiwai nui kēia ʻano biotechnology, hiki ke hana i nā protein i hiki ke paʻakikī ke loaʻa i ka nui a i ʻole me nā hoʻololi maʻamau me ka hoʻohana ʻana i nā ʻano kuʻuna. Hāʻawi nā protein recombinant i kahi pūʻulu nui o nā pono i ka ʻepekema ola, ʻoiai lākou e ʻae ai i ka hana ʻana o nā huahana protein makemake nui ʻia me nā hua kiʻekiʻe i nā huahana nui
Eia kekahi, na me ka hoʻohana ʻana i nā ʻano hana genetic engineering e hoʻololi i ke kaʻina DNA e hoʻopili ana i kahi protein kikoʻī, hiki ke hoʻoulu i nā hoʻololi i loko o kona ʻano, hana, a i ʻole nā mea waiwai ʻē aʻe, e lawelawe ana ma ke ʻano he mea e ʻenekinia recombinant proteins with tailored characteristics to meet diverse requirements. This inherent adaptability for custom protein production extends beyond the creation of novel proteins for distinct purposes, but it also encompasses the enhancement of existing ones.
Hoʻohana ʻia ka protein recombinant
Nui nā ʻano o nā protein recombinant, kēlā me kēia me nā ʻano ʻokoʻa o nā noi, akā ʻo ka hapa nui o lākou ua lilo i mea nui i nā ʻano like ʻole. kahua lapaau.
Eia kekahi lā, ma ka lāʻau kūʻai lāʻau, ʻo ka hana ʻana o nā protein recombinant ka mea nui no ka hoʻomohala ʻana i nā lāʻau lapaʻau a me nā mea lapaʻau, no ka mea, lawelawe pinepine lākou ma ke ʻano he lāʻau lapaʻau ikaika i loko meaola lāʻau lapaʻau. No ka laʻana, hana pinepine ʻia nā antibodies recombinant e like me nā antibodies monoclonal a i ʻole immunoglobulin antibodies a me nā ʻano hana lapaʻau holomua ʻē aʻe me ka hoʻohana ʻana i kēia ʻōnaehana protein maʻamau. Eia kekahi, ua loli ka pololei a me ka scalability o ka ʻenehana protein recombinant hoʻomohala lāʻau, hiki i ka hana ʻana i nā protein therapeutic standard kiʻekiʻe e like me ka insulin, nā mea ulu a i ʻole kekahi mau hormones.
Ma ke kahua o nā diagnostics, i ka hoʻonui ʻana o ka hana a me ka loaʻa ʻana o nā protein recombinant, ʻo lākou hoʻohana ʻia i ka hoʻomohala ʻana i nā hoʻokolohua koʻikoʻi loa a kikoʻī no nā maʻi like ʻole. No ka laʻana, inā ʻaʻole hiki ke hoʻomaʻamaʻa ʻia kahi maʻi maʻi, ke hāʻawi ʻia i kāna kaʻina gene, hiki iā ia ke pane wikiwiki i nā maʻi e puka mai ana a i ʻole nā maʻi viral hou me kahi hoʻāʻo ELISA i hana ʻia ma o ka hoʻohana ʻana i nā protein recombinant o ka maʻi kikoʻī.
Ke kuleana koʻikoʻi ma ka noiʻi
In noiʻi, ua koʻikoʻi lākou no ka ke aʻo ʻana i ka hana protein a me nā pilina, he mea nui ia no ka hoʻomaopopo ʻana i nā kaʻina hana olaola a me nā mīkini maʻi. Eia kekahi, hoʻohana ʻia nā ʻenehana loea e like me ka surface plasmon resonance no ka nānā ʻana i kā lākou mau pilina, e hāʻawi ana i ka ʻike hohonu o kā lākou kuleana olaola a me ka loaʻa ʻana o ka ʻike i nā waiwai hana o kēia mau protein. No ka laʻana, e hōʻike ana i nā protein i loko E. coli has allowed biomedical research to study intricate biochemical pathways and decipher the molecular mechanisms underlying various biological processes. Moreover, using genome editing tools like CRISPR CAS9 or Cre-lox technology, the use of recombinant proteins of genes such as Rag 1 and Rag 2 or the CNTF gene has provided valuable insight into the regulation of gene expression, signal transduction pathways, and the intricate interplay between different cellular components.
Eia kekahi, ʻo ka hoʻohana ʻana i ka protein recombinant i ka ʻenehana ʻaʻole ia he kumu nui i ka lāʻau lapaʻau akā i nā ʻano ʻē aʻe e like me ka mahiʻai a me ka ʻenehana meaʻai hou, hāʻawi i nā ʻōlelo hoʻohiki i nā pilikia paʻakikī i ka ʻoihana biotech. Ke hoʻomau nei kēia ʻenehana i ka ulu ʻana, hiki i kona hiki ke hoʻololi hou i kā mākou ala i ka ʻepekema ola, ma ka noiʻi a me nā noi ʻoihana, a ma TECNIC makemake mākou e lilo i ʻāpana o nā hoʻonā holomua hou loa i ulu like.
Nā pilikia i ka hana ʻana i ka protein recombinant
This biotechnology requires an enormous amount of resources and know-how, and failures in manufacturing can have severe consequences as well as financial drawbacks. Its common challenges encompass issues related to efficiency, purity and scalability and demand careful consideration and sophisticated solutions for optimal outcomes.
ʻO ke koʻikoʻi o TFF i ka hana ʻana i nā protein recombinant
I mea e hana ai i nā protein recombinant kiʻekiʻe me nā hua kiʻekiʻe a me nā hopena kūlike, pono e hana me ka lako pono, inā ʻoe e hana ana i nā antibodies therapeutic no nā kumu noiʻi a i ʻole ka hana ʻana i nā enzyme nui no ka ʻoihana. E like me ka hoʻonā mua, TECNIC Bioreactors ⇀ kū i waho no upstream hana bioprocessing protein recombinant, e hoʻoponopono i nā pilikia koʻikoʻi me ka ʻike i kēlā me kēia pae, mai ka noiʻi a hiki i ka hana ʻoihana nui.
E ʻae iā mākou e hāʻawi i ka mana pololei ma luna o nā ʻāpana āpau āpau, ʻoi aku ka maikaʻi o nā kūlana cellular a i ʻole microbial no ka loaʻa ʻana o ka protein me ka hoʻemi ʻana i ka waiwai a me ka hoʻohana manawa. ʻO ka hiki ke nānā pono e hōʻoia i ka maikaʻi loa i ka bioprocess a me ka TECNIC automatic control unit of eLAB, ePILOT a me ePROD ⇀ , me kahi PLC ʻoihana, hiki iā ʻoe ke hoʻoponopono maikaʻi i kāu kūlana moʻomeheu e loaʻa i nā hopena reproducible a kūlike.
Ke hoʻokō ʻia ka pae hope o ka moʻomeheu, he mea mua ke loaʻa a maikaʻi ka hopena hopena. ʻO ka holomua downstream Hoʻoheheʻe ʻia ʻo Tangential Flow o TECNIC ⇀ hoʻokaʻawale maikaʻi i ka protein target mai nā haumia a me nā mea haumia, e hōʻoia i kahi kiʻekiʻe o ka maʻemaʻe me nā kahe kahe kiʻekiʻe. Also, thanks to its fully automatic system and variety of operational options, eLAB TFF ⇀ , ePILOT TFF ⇀ a ePROD TFF ⇀ hāʻawi i ka maʻemaʻe hope loa o kāu bioprocess holoʻokoʻa.
ʻO ka hope, hāʻawi ʻia i ka scalability inherent o kā mākou lako, TECNICʻO nā bioreactors a me ka ʻōnaehana tangential hiki ke hōʻoia i ka hilinaʻi a me ka pono e pono ai e hoʻokō i ka noi hope no nā protein recombinant kiʻekiʻe. No laila, inā ʻoe e hana nei i ka noiʻi paionia a i ʻole ka hoʻokele ʻana i ka hana ʻenehana, TECNIC'O ka ho'opa'a 'ana 'o ia ka hopena e ulu like ai.
Nā moʻolelo kūleʻa a me nā noi
ʻOiai ʻaʻole hiki iā mākou ke hāʻawi i nā kikoʻī kikoʻī ma muli o ka hūnā, ua nui nā manawa i loaʻa ai TECNICUa hoʻonui nui nā mea hana i ka hana ʻana i nā protein recombinant. Ua hilinaʻi kā mākou mau mea kūʻai aku iā mākou, a me ka holomua o nā mea i hāʻawi ʻia TECNIC Hōʻike nā hāʻina i ko mākou kūlana maikaʻi a me ka hoʻokō ʻana e ulu pū.
No ka laʻana, ma ke ʻano o ka noiʻi meaʻai hou, ua manaʻo kekahi o kā mākou mea kūʻai aku e hana i ka hua manu i nā polokina hana nui me ka hoʻohana ʻana i kahi kumu holoholona ʻole. ʻOiai ua loaʻa iā lākou ka ʻenehana a me ka ʻike, ua loaʻa iā lākou nā pilikia i ka wā o ka Scale-Up production. Leveraging ka TECNIC eLAB Advanced Bioreactor, ua hiki iā lākou ke hoʻoikaika i ka ʻōnaehana hōʻike, e alakaʻi ana i kahi piʻi nui i ka hua a me ka maʻemaʻe. Eia kekahi, ʻo ka versatility o kēia mea hana, i hui pū ʻia me kāna mau hiʻohiʻona scalability, hiki iā lākou ke hana maʻalahi me nā moku he nui no nā pae like ʻole o ke kaʻina hana. ʻO ka hopena, ua hoʻokō kā mākou mea kūʻai aku i kā lākou mau pahuhopu hana me ka hoʻonui ʻana i ka maikaʻi a me ka maikaʻi o ka huahana, e loaʻa ana nā hopena maikaʻi loa no kā lākou papahana.
ʻO kā mākou kūpaʻa i nā papahana a kā mākou mea kūʻai aku e hōʻoiaʻiʻo e hoʻomau mākou i nā hana hou a i ʻole nā kōkua hou e koi ʻia, a i kēia manawa, ke hāʻawi nei mākou i ke kākoʻo mau a me ka hoʻomau ʻana i kēia papahana mea kūʻai aku.
Ma ka ʻoihana lāʻau lapaʻau, TECNIC hoʻohana ʻia e hui pū me nā ʻoihana ua kālele ʻia i ka hana nui ʻana o nā huahana biotech pharma e like me monoclonal antibodies ⇀, lāʻau anticancer, nā lāʻau lapaʻau ⇀, A oi.
ʻO kēia mau huahana lāʻau lapaʻau a me nā huahana biotechnology e koi pinepine i ka hoʻohana ʻana nā bioreactors no ka mea, upstream kaʻina hana a downstream ʻōnaehana kānana tangential e hōʻoia i ka hua maikaʻi loa, ka maʻemaʻe, a me ka scalability.
ʻo kahi laʻana, TECNIC ua komo nui i ka hana nui o ka ʻO ka antibiotic therapeutic hou i hoʻolālā ʻia no nā holoholona. Ma kēia hana biotechnological kikoʻī, hoʻokani kā mākou mea hana ePROD i kahi hana koʻikoʻi, e hāʻawi ana i ka pololei a me ka mana kūpono o ka bioprocess e hōʻoia i nā hua kiʻekiʻe i manaʻo ʻia no kēia papahana. Ma hope iho, hoʻokaʻawale maikaʻi kā mākou ePROD TFF i ka peptide target mai ka moʻomeheu media a me nā mea haumia ʻē aʻe. I kēia manawa, loaʻa ka papahana holoʻokoʻa i kahi kiʻekiʻe o ka maʻemaʻe i hui pū ʻia me nā uku hoʻohua maikaʻi, he hōʻike i kā mākou kūpaʻa i ka holomua o ka mea kūʻai aku ma o ka hāʻawi ʻana i nā hopena maikaʻi loa i kēlā me kēia pae o ka bioprocess.
E ʻimi i kā mākou ʻano lako lako
E ʻimi i ka mua o ka protein recombinant me kā mākou mea hana kiʻekiʻe. Hoʻolālā ʻia kā mākou bioreactors no nā noi like ʻole, e hōʻoia ana i ka pono a me ka maikaʻi. E ʻike i kā mākou hui piha o nā ʻōnaehana biotechnology, me Bioreactors, Tangential Flow Filtration system, a me nā mea hou aku. E kipa i kā mākou ʻaoʻao no Bioreactors ⇀, Hoʻokaʻawale ʻia ke kahe ʻana ⇀, a Hoʻokaʻaʻike ⇀ no ka mea hou information a me na ninau.
